Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Barclays Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Fri Mar 13, 2:42AM CDT

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA today and set a price target of €46.50.

Claim 70% Off TipRanks Premium

According to TipRanks, Al-Wakeel is an analyst with an average return of -1.2% and a 45.52% success rate. Al-Wakeel covers the Healthcare sector, focusing on stocks such as Straumann Holding AG, EssilorLuxottica SA, and Siemens Healthineers AG.

In addition to Barclays, Fresenius Medical Care AG & Co. KGaA also received a Hold from Kepler Capital ‘s Oliver Reinberg in a report issued on March 10. However, on the same day, UBS maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See Insiders’ Hot Stocks on TipRanks >>

0H9X market cap is currently €11.4B and has a P/E ratio of 12.14.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).